- Messages
- 79,281
- Reaction score
- 45,652
NFL to test for more performance-enhancing drugs
Associated Press
NEW YORK -- The NFL and its players union have agreed to more extensive testing for performance-enhancing drugs and have added the blood-boosting substance EPO to the league's list of banned substances.
The agreement, announced jointly Wednesday by the league and union, also adds to the financial penalties for players suspended for using those drugs. Players suspended for using steroids or other performance-enhancing drugs will forfeit a prorated portion of their signing bonuses.
Signing bonuses often are the only guaranteed portion of a player's compensation.
In addition to the new test for EPO, the deal includes an increase from seven to 10 of the number of players on each team randomly tested each week during the season for steroids and other performance-enhancing drugs. That means there will be 12,000 tests each season, up from the current 10,000.
"It is important that the NFL and its players continue to be leaders on the issue of illegal and dangerous performance-enhancing drugs in sports," said NFL commissioner Roger Goodell. "These latest improvements will help ensure that we continue to have a strong and effective program. As we have done in the past, we will review and modify the policy on an ongoing basis."
The enhancements to the drug policy have been pending for almost six months -- from about the time Goodell succeeded Paul Tagliabue as commissioner. The league and union began negotiating on additional tests and substances in September, but didn't reach agreement until this week.
Those discussions followed congressional reaction to a story in the Charlotte Observer on steroid prescriptions given to Carolina Panthers players by a South Carolina doctor during the 2003 season, which ended with Carolina losing the Super Bowl to New England.
One provision of the agreement increases the unpredictability of random testing during the season and offseason, making it harder for players using performance-enhancing substances to regulate their usage because they won't know when they might be tested.
EPO, which provides users more stamina by increasing their number of red blood cells, is used primarily by long-distance runners and cyclists. That testing will begin this summer when teams go to training camp.
The program also includes additional use of carbon isotope ratio testing on a random basis to detect for doses of testosterone. All players now will be subject to those tests, previously used only to confirm positive tests.
The NFL also agreed to a $500,000 grant to the UCLA Olympic testing laboratory and other researchers for further testing on HGH _ human growth hormone. The league also will establish a group to study issues related to HGH.
In addition, the NFL Youth Football fund, endowed by both the league and union, has approved a $1.2 million steroids education fund at the Center for Health Promotion Research at the Oregon Health and Science University (OHSU) in Portland, Ore.
LINK
Associated Press
NEW YORK -- The NFL and its players union have agreed to more extensive testing for performance-enhancing drugs and have added the blood-boosting substance EPO to the league's list of banned substances.
The agreement, announced jointly Wednesday by the league and union, also adds to the financial penalties for players suspended for using those drugs. Players suspended for using steroids or other performance-enhancing drugs will forfeit a prorated portion of their signing bonuses.
Signing bonuses often are the only guaranteed portion of a player's compensation.
In addition to the new test for EPO, the deal includes an increase from seven to 10 of the number of players on each team randomly tested each week during the season for steroids and other performance-enhancing drugs. That means there will be 12,000 tests each season, up from the current 10,000.
"It is important that the NFL and its players continue to be leaders on the issue of illegal and dangerous performance-enhancing drugs in sports," said NFL commissioner Roger Goodell. "These latest improvements will help ensure that we continue to have a strong and effective program. As we have done in the past, we will review and modify the policy on an ongoing basis."
The enhancements to the drug policy have been pending for almost six months -- from about the time Goodell succeeded Paul Tagliabue as commissioner. The league and union began negotiating on additional tests and substances in September, but didn't reach agreement until this week.
Those discussions followed congressional reaction to a story in the Charlotte Observer on steroid prescriptions given to Carolina Panthers players by a South Carolina doctor during the 2003 season, which ended with Carolina losing the Super Bowl to New England.
One provision of the agreement increases the unpredictability of random testing during the season and offseason, making it harder for players using performance-enhancing substances to regulate their usage because they won't know when they might be tested.
EPO, which provides users more stamina by increasing their number of red blood cells, is used primarily by long-distance runners and cyclists. That testing will begin this summer when teams go to training camp.
The program also includes additional use of carbon isotope ratio testing on a random basis to detect for doses of testosterone. All players now will be subject to those tests, previously used only to confirm positive tests.
The NFL also agreed to a $500,000 grant to the UCLA Olympic testing laboratory and other researchers for further testing on HGH _ human growth hormone. The league also will establish a group to study issues related to HGH.
In addition, the NFL Youth Football fund, endowed by both the league and union, has approved a $1.2 million steroids education fund at the Center for Health Promotion Research at the Oregon Health and Science University (OHSU) in Portland, Ore.
LINK
